These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 35438)
61. Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital. Schröder H; Lewkonia RM; Price Evans DA Clin Pharmacol Ther; 1973; 14(5):802-9. PubMed ID: 4147120 [No Abstract] [Full Text] [Related]
62. Sulfasalazine vs. steroids in Crohn's disease: David vs. Goliath? Hanauer SB Gastroenterology; 1991 Oct; 101(4):1130-1. PubMed ID: 1679735 [No Abstract] [Full Text] [Related]
63. Biologics in fistulizing Crohn's disease: so near, yet so far. Atreja A; Bahuva R; Sands BE Am J Gastroenterol; 2011 Nov; 106(11):2045-6; author reply 2046. PubMed ID: 22056584 [No Abstract] [Full Text] [Related]
64. Efficacy of certolizumab pegol in Crohn's disease: response to ford et Al. Kayhan C; Pierre-Louis B; Sen D; Serna M Am J Gastroenterol; 2012 Feb; 107(2):321; author reply 321-2. PubMed ID: 22306947 [No Abstract] [Full Text] [Related]
65. A modest proposal for future trials of medical treatment in inflammatory bowel disease. Janowitz HD Gut; 1994 Jun; 35(6):860. PubMed ID: 8020822 [No Abstract] [Full Text] [Related]
66. Crohn's disease: we are in it for the long haul. Interview by Paul C Adams. Panaccione R Can J Gastroenterol; 2008 Oct; 22(10):803-4. PubMed ID: 19006852 [No Abstract] [Full Text] [Related]
67. Sulphasalazine in asymptomatic Crohn's disease. A multicentre trial. Lennard-Jones JE Gut; 1977 Jan; 18(1):69-72. PubMed ID: 14057 [TBL] [Abstract][Full Text] [Related]
68. Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical Trials. Sedano R; Hogan M; McDonald C; Aswani-Omprakash T; Ma C; Jairath V Inflamm Bowel Dis; 2022 Aug; 28(8):1293-1295. PubMed ID: 35078220 [TBL] [Abstract][Full Text] [Related]
70. When meta-analysis misleads. Yang M; Robinson AM; Pollack PF Am J Gastroenterol; 2011 Nov; 106(11):2043; author reply 2044. PubMed ID: 22056581 [No Abstract] [Full Text] [Related]
71. Amenorrhea in women treated with thalidomide: report of two cases and literature review. Lazzerini M; Bramuzzo M; Martelossi S; Magazzù G; Pellegrino S; Ventura A Inflamm Bowel Dis; 2013 Jan; 19(1):E10-1. PubMed ID: 22161965 [No Abstract] [Full Text] [Related]
72. Nicotine and gastrointestinal disease. Thomas GA; Rhodes J; Green J QJM; 1996 Jul; 89(7):485-8. PubMed ID: 8759486 [No Abstract] [Full Text] [Related]
73. The New Era of Nutraceuticals: Beneficial Effects of Polyphenols in Various Experimental and Clinical Settings. Magrone T; Jirillo E Curr Pharm Des; 2018; 24(44):5229-5231. PubMed ID: 30973101 [No Abstract] [Full Text] [Related]
74. Golimumab (Simponi) for ulcerative colitis. Med Lett Drugs Ther; 2014 Mar; 56(1439):25-6. PubMed ID: 24691148 [No Abstract] [Full Text] [Related]
75. Metronidazole in Crohn's disease. Gilat T Gastroenterology; 1982 Sep; 83(3):702-4. PubMed ID: 6124478 [No Abstract] [Full Text] [Related]
76. [Results of treatment with sulfasalazine in the American Multicenter Study on the treatment of Crohn disease (National Cooperative Crohn's Disease Study)]. Singleton JW Z Gastroenterol Verh; 1981 Jun; 19():38-40. PubMed ID: 6168133 [No Abstract] [Full Text] [Related]
77. Medical treatment of ulcerative colitis and Crohn's disease. Rhodes JM J Clin Hosp Pharm; 1983 Sep; 8(3):219-32. PubMed ID: 6138368 [No Abstract] [Full Text] [Related]
78. Current status of drug therapy for inflammatory bowel disease. Peppercorn MA Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866 [TBL] [Abstract][Full Text] [Related]
79. [Therapeutic trials in Crohn's disease and ulcerative colitis: ethics, objectives and methodology. A G.R.E.C. cooperative study]. Hecketsweiler P; Bernier JJ; Geffroy Y Gastroenterol Clin Biol; 1979 Jan; 3(1):67-72. PubMed ID: 35438 [No Abstract] [Full Text] [Related]